Medline to Consider Pricing US IPO at $29 Per Share
Summarize this article with:
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000US Stocks:Medline Inc. is considering pricing its initial public offering at $29 per share, according to people familiar with the matter.The medical supplies company, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, is discussing a potential upsize to the offering to raise as much as $7 billion, one of the people said, asking not to be identified because the information isn’t public.